|
Market Closed -
Other stock markets
|
After hours 08:00:00 pm | |||
| 198.99 USD | -1.86% |
|
198.85 | -0.07% |
| Jul. 17 | RBC Downgrades ResMed to Sector Perform From Outperform, Cuts Price Target to $234 From $276 | MT |
| Jul. 15 | Mizuho Adjusts Price Target on ResMed to $220 From $235, Maintains Outperform Rating | MT |
Chart calendar ResMed, Inc.
Upcoming events on ResMed, Inc.
| 2026-08-06 | Earnings release - Q4 2026 | |
| 2026-08-06 | Earnings presentation | 04:30 pm |
Past events on ResMed, Inc.
| 2026-04-30 | Earnings release - Q3 2026 | |
| 2026-04-30 | Earnings presentation | 04:30 pm |
| 2026-01-29 | Earnings presentation | 04:30 pm |
| 2026-01-29 | Earnings release - Q2 2026 | |
| 2025-11-19 | Présentation aux Actionnaires / Analystes | 06:00 pm |
| 2025-11-19 | Annual General Meeting | 06:00 pm |
| 2025-10-30 | Earnings presentation | 04:30 pm |
| 2025-10-30 | Earnings release - Q1 2026 | |
| 2025-07-31 | Earnings release - Q4 2025 | |
| 2025-07-31 | Earnings presentation | 04:30 pm |
Past dividends on ResMed, Inc.
| 2026-05-14 | Ex-dividend date - 0.6 USD | 12:00 am |
| 2026-02-12 | Ex-dividend date - 0.6 USD | 12:00 am |
| 2025-11-13 | Ex-dividend date - 0.6 USD | 12:00 am |
| 2025-08-14 | Ex-dividend date - 0.6 USD | 12:00 am |
Annual results
| Fiscal Period | June | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 4 223 4 235 -0.29% | 4 685 4 678 0.16% | 5 146 5 128 0.36% | 5 650 | 6 024 | 6 416 |
|
EBITDA Million USD | Released Forecast Spread | 1 317 1 351 -2.52% | 1 576 1 577 -0.1% | 1 884 1 862 1.18% | 2 191 | 2 342 | 2 520 |
|
EBIT Million USD | Released Forecast Spread | 1 224 1 230 -0.47% | 1 478 1 462 1.13% | 1 763 1 738 1.45% | 2 033 | 2 172 | 2 337 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 102 1 114 -1.13% | 1 265 1 280 -1.2% | 1 678 1 669 0.53% | 1 967 | 2 204 | 2 454 |
|
Net income Million USD | Released Forecast Spread | 898 901 -0.42% | 1 021 1 023 -0.23% | 1 401 1 364 2.69% | 1 547 | 1 671 | 1 828 |
|
EPS USD | Released Forecast Spread | 6,09 6,14 -0.84% | 6,92 6,99 -1.06% | 9,51 9,31 2.2% | 10,6 | 11,6 | 12,6 |
| Announcement Date | 03/08/23 | 01/08/24 | 31/07/25 | - |
Quarterly results
| Fiscal Period | March | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 | 2028 Q1 | 2028 Q2 | 2028 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 225 1 183 3.52% | 1 282 1 267 1.18% | 1 292 1 284 0.58% | 1 348 1 331 1.31% | 1 336 1 333 0.2% | 1 423 1 398 1.76% | 1 431 1 422 0.63% | 1 457 | 1 429 | 1 506 | 1 512 | 1 514 | |||
|
EBITDA Million USD | Released Forecast Spread | 432 413 4.59% | 464 463 0.2% | 470 474 -0.87% | 519 495 4.86% | 510 509 0.28% | 547 551 -0.6% | 559 558 0.07% | 575 | 557 | 584 | 592 | 566 | |||
|
EBIT Million USD | Released Forecast Spread | 406 383 6.08% | 436 429 1.68% | 445 439 1.36% | 476 456 4.52% | 482 471 2.34% | 517 507 2.05% | 525 519 1.11% | 526 | 542 | 577 | 580 | ||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 383 364 5.33% | 418 408 2.59% | 418 421 -0.89% | 458 445 3.01% | 447 455 -1.84% | 496 491 1.01% | 502 508 -1.13% | 514 | |||||||
|
Net income Million USD | Released Forecast Spread | 311 292 6.65% | 345 328 4.95% | 365 338 7.98% | 380 354 7.23% | 349 357 -2.4% | 393 387 1.32% | 399 399 0% | 402 | |||||||
|
EPS USD | Released Forecast Spread | 2,11 1,95 7.97% | 2,34 2,23 5.14% | 2,48 2,29 8.32% | 2,58 2,41 7.25% | 2,37 2,44 -2.97% | 2,68 2,64 1.64% | 2,74 2,72 0.7% | 2,80 | 2,82 | 3,03 | 3,03 | 3,09 | 3,07 | 3,30 | 3,29 |
| Announcement Date | 24/10/24 | 30/01/25 | 23/04/25 | 31/07/25 | 30/10/25 | 29/01/26 | 30/04/26 | - | - | - | - | - | - | - | - |
| 2026-07-20 |  | Extraordinary General Meeting | 02:00 am |
| 2026-07-21 | | Earnings presentation | 08:00 am |
| 2026-07-21 | | Earnings release - Q2 2026 | 06:00 am |
| 2026-07-23 | | Earnings presentation | 08:30 am |
| 2026-07-23 | | Earnings release - Q2 2026 | |
| 2026-07-23 | | Earnings presentation | 05:00 pm |
| 2026-07-23 | | Earnings release - Q2 2026 | |
| 2026-07-23 | | Extraordinary General Meeting | 02:00 am |
| 2026-07-24 | | Ex-dividend date - 0.035 USD | 12:00 am |
| 2026-07-26 | | Sales and Revenue Release - Q2 2026 | *E4DFANSWAPTOBAIJ22ORFMMWNCSDVOFTFBPAR |
Past sector events for ResMed, Inc.
| 2026-07-17 | | Ex-dividend date - 0.07 USD | 12:00 am |
| 2026-07-16 | | Earnings release - Q2 2026 | |
| 2026-07-16 | | Earnings presentation | 04:30 pm |
| 2026-07-12 | | Sales and Revenue Release - Q2 2026 | |
| 2026-07-10 | | Significant Split/Dividend | 12:00 am |
| 2026-07-10 | | Ex-dividend date - 0.2 CNY | 12:00 am |
| 2026-07-10 | | Significant Split/Dividend | 12:00 am |
| 2026-07-06 | | Board of Directors Meeting | |
| 2026-06-30 | | Ex-dividend date - 0.255 USD | 12:00 am |
| 2026-06-29 | | Annual General Meeting | 10:00 pm |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RMD Stock
- Calendar ResMed, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
